Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126761482 | 12676148 | 2 | F | 20160706 | 20160818 | 20160823 | 20160829 | EXP | PHHY2016IT108074 | NOVARTIS | 80.50 | YR | M | Y | 73.00000 | KG | 20160829 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126761482 | 12676148 | 1 | PS | GLIVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD (DAILY) | 5200 | MG | Y | 21588 | 400 | MG | QD | ||||
| 126761482 | 12676148 | 2 | SS | GLIVEC | IMATINIB MESYLATE | 1 | Oral | UNK | 5200 | MG | Y | 21588 | |||||||
| 126761482 | 12676148 | 3 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, QD | 6000 | MG | Y | 0 | 300 | MG | QD | ||||
| 126761482 | 12676148 | 4 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | UNK | 6000 | MG | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126761482 | 12676148 | 1 | Chronic myeloid leukaemia |
| 126761482 | 12676148 | 3 | Hyperuricaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126761482 | 12676148 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126761482 | 12676148 | Dermatitis exfoliative | |
| 126761482 | 12676148 | Drug hypersensitivity | |
| 126761482 | 12676148 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126761482 | 12676148 | 1 | 20160624 | 20160714 | 0 | |
| 126761482 | 12676148 | 2 | 20160718 | 0 | ||
| 126761482 | 12676148 | 3 | 20160617 | 20160714 | 0 | |
| 126761482 | 12676148 | 4 | 20160718 | 0 |